Karlsson E, Molin L, Norlander B, Sjoqvist F
Br J Clin Pharmacol. 2012; 1(6):467-75.
PMID: 22454932
PMC: 1402529.
DOI: 10.1111/j.1365-2125.1974.tb01696.x.
Hwang S, Kwan K, Albert K
J Pharmacokinet Biopharm. 1981; 9(6):693-709.
PMID: 7341755
DOI: 10.1007/BF01070901.
Olsen H, Morland J
Br J Clin Pharmacol. 1982; 13(2):203-8.
PMID: 7059417
PMC: 1402013.
DOI: 10.1111/j.1365-2125.1982.tb01357.x.
Brown J, SHAND D
Clin Pharmacokinet. 1982; 7(2):125-48.
PMID: 7039925
DOI: 10.2165/00003088-198207020-00003.
Juchau M, Chao S, Omiecinski C
Clin Pharmacokinet. 1980; 5(4):320-39.
PMID: 6994979
DOI: 10.2165/00003088-198005040-00002.
New antiarrhythmic drugs: their place in therapy.
Keefe D, Kates R, Harrison D
Drugs. 1981; 22(5):363-400.
PMID: 6800757
DOI: 10.2165/00003495-198122050-00002.
Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark D
Drugs. 1985; 29(4):342-75.
PMID: 2859977
DOI: 10.2165/00003495-198529040-00003.
Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.
Harron D, Brogden R
Drugs. 1990; 39(5):720-40.
PMID: 1693889
DOI: 10.2165/00003495-199039050-00007.
Procainamide absorption studies to test the feasibility of using a sustained-release preparation.
Shaw T, Kumana C, Kaye C, Padgham C, Kaspi T, Hamer J
Br J Clin Pharmacol. 1975; 2(6):515-9.
PMID: 1234015
PMC: 1402637.
DOI: 10.1111/j.1365-2125.1975.tb00569.x.
Pharmacokinetics in man of the N-acetylated metabolite of procainamide.
Strong J, Dutcher J, Lee W, Atkinson Jr A
J Pharmacokinet Biopharm. 1975; 3(4):223-35.
PMID: 1185521
DOI: 10.1007/BF01066919.
Comparison of the acetylation of procainamide and sulfadimidine in man.
Frislid K, Berg M, Hansteen V, Lunde P
Eur J Clin Pharmacol. 1976; 09(5-6):433-8.
PMID: 971707
DOI: 10.1007/BF00606561.
Polymorphic acetylation of sulphadimidine in normal and uraemic man.
Talseth T, Landmark K
Eur J Clin Pharmacol. 1977; 11(1):33-6.
PMID: 832655
DOI: 10.1007/BF00561785.
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Anderson J, Harrison D, Meffin P, Winkle R
Drugs. 1978; 15(4):271-309.
PMID: 648399
DOI: 10.2165/00003495-197815040-00003.
Serum procainamide levels as therapeutic guides.
Koch-Weser J
Clin Pharmacokinet. 1977; 2(6):389-402.
PMID: 589880
DOI: 10.2165/00003088-197702060-00001.
Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.
Sonnhag C, Karlsson E
Eur J Clin Pharmacol. 1979; 15(5):311-7.
PMID: 378673
DOI: 10.1007/BF00558433.
Disease and acetylation polymorphism.
Lunde P, Frislid K, Hansteen V
Clin Pharmacokinet. 1977; 2(3):182-97.
PMID: 328206
DOI: 10.2165/00003088-197702030-00003.
